Isolation of Circulating Tumor Cells to Diagnose Melanoma and Evaluate the Efficacy of Surgical Resection Using Melanoma‐Specific Microsystem-Reference-Cited by-同舟云学术

Isolation of Circulating Tumor Cells to Diagnose Melanoma and Evaluate the Efficacy of Surgical Resection Using Melanoma‐Specific Microsystem

Published:2022-04-19 Issue:8 Volume:2 Page:2100083
ISSN:2699-9307
Container-title:Advanced NanoBiomed Research
language:en
Short-container-title:Advanced NanoBiomed Research

Author:

Kang Yoon-Tae¹,Mutukuri Anusha¹,Hadlock Thomas¹,Fairbairn Heather¹,Carle Taylor R.²,Fouladdel Shamileh¹,Murlidhar Vasudha¹,Kramer Aaron¹,Reguera Monica De Silva¹,Azizi Ebrahim³,Durham Alison²,Mclean Scott A.²,Nagrath Sunitha¹⁴^ORCID

Affiliation:

1. Department of Chemical Engineering and Biointerface Institute University of Michigan 2800 Plymouth Road, NCRC B10-A184 Ann Arbor MI 48109 USA

2. Michigan Medicine Otolaryngology Clinic Taubman Center University of Michigan Ann Arbor MI 48109 USA

3. Biointerfaces Institute (BI) Translational Oncology Program (TOP) Department of Internal Medicine University of Michigan 2800 Plymouth Road Ann Arbor MI 48109 USA

4. Roger Cancer Center University of Michigan 1500 E Medical Center Dr Ann Arbor MI 48109 USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anbr.202100083

Reference52 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Metastatic Melanoma – A Review of Current and Future Treatment Options